10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001213900-21-058454`
Period End Date	20210930
Filing Date	20211112
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	f10q0921_relmadatherap_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 54 Income Statement 44 Cash Flow Statement 56 Stockholders Equity 47

Balance Sheet 54 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`Cash`	$11.45M	USD	Point-in-time
Cash and cash equivalents	`Cash`	$2.50M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$76.64M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$114.60M	USD	Point-in-time
Lease payments receivable short term	`LeasePaymentsReceivableShortTerm`	$79.46K	USD	Point-in-time
Lease payments receivable short term	`LeasePaymentsReceivableShortTerm`	$84.59K	USD	Point-in-time
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$903.19K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$2.72M	USD	Point-in-time
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$90.89M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$118.07M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$1.26K	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$25.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Lease payments receivable long term	`LeasePaymentsReceivableLongTerm`	$22.27K	USD	Point-in-time
Lease payments receivable long term	`LeasePaymentsReceivableLongTerm`	$86.38K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$90.93M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Total assets	`Assets`	$118.19M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	16.33M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	17.50M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	17.50M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	16.33M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$12.71M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.35M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.54M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.26M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.25M	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue1`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue1`	-	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 17,501,554 and 16,332,939 shares issued and outstanding, respectively	`CommonStockValue`	$16.33K	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 17,501,554 and 16,332,939 shares issued and outstanding, respectively	`CommonStockValue`	$17.50K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$284.88M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$343.36M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-179.32M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-270.69M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$72.69M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$105.58M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$90.93M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$118.19M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$65.35M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$11.24M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$33.99M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$21.07M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$26.17M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.95M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$18.85M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.66M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$42.65M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$17.18M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$39.92M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$91.52M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-39.92M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-42.65M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-91.52M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-17.18M	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$297.65K	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$1.17M	USD	3 Qtrs
Interest/investment income, net	`InterestIncomeExpenseNet`	$363.30K	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$1.04M	USD	3 Qtrs
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-86.17K	USD	1 Quarter
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-513.33K	USD	3 Qtrs
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-336.95K	USD	1 Quarter
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-244.97K	USD	3 Qtrs
Unrealized gain (loss) on short-term investments	`UnrealizedGainLossOnInvestments`	$-379.70K	USD	3 Qtrs
Unrealized gain (loss) on short-term investments	`UnrealizedGainLossOnInvestments`	$290.97K	USD	3 Qtrs
Unrealized gain (loss) on short-term investments	`UnrealizedGainLossOnInvestments`	$3.95K	USD	1 Quarter
Unrealized gain (loss) on short-term investments	`UnrealizedGainLossOnInvestments`	$86.75K	USD	1 Quarter
Total other income - net	`NonoperatingIncomeExpense`	$281.07K	USD	1 Quarter
Total other income - net	`NonoperatingIncomeExpense`	$47.44K	USD	1 Quarter
Total other income - net	`NonoperatingIncomeExpense`	$1.22M	USD	3 Qtrs
Total other income - net	`NonoperatingIncomeExpense`	$147.40K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-16.90M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-38.69M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-42.61M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-91.37M	USD	3 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-2.52	USD	3 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.05	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-5.36	USD	3 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-2.44	USD	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	16.04M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	17.04M	shares	3 Qtrs
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.37M	shares	3 Qtrs
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	17.48M	shares	1 Quarter

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-91.37M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-38.69M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$1.26K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$2.93K	USD	3 Qtrs
Warrants issued for license agreement	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs
Warrants issued for license agreement	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$10.24M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$22.13M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$17.59M	USD	3 Qtrs
Realized loss on short-term investments	`IncomeLossFromEquityMethodInvestments`	$-244.97K	USD	3 Qtrs
Realized loss on short-term investments	`IncomeLossFromEquityMethodInvestments`	$-513.33K	USD	3 Qtrs
Unrealized loss/(gain) on short-term investments	`UnrealizedlossGainOnShorttermInvestments`	$290.97K	USD	3 Qtrs
Unrealized loss/(gain) on short-term investments	`UnrealizedlossGainOnShorttermInvestments`	$-379.70K	USD	3 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-54.24K	USD	3 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-58.97K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.83M	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.81M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$205.97K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.36M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.84M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.28M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-54.21M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-20.88M	USD	3 Qtrs
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$82.48M	USD	3 Qtrs
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$88.76M	USD	3 Qtrs
Sale of short-term investments	`ProceedsFromSaleAndMaturityOfOtherInvestments`	$53.38M	USD	3 Qtrs
Sale of short-term investments	`ProceedsFromSaleAndMaturityOfOtherInvestments`	$119.54M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-35.38M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$37.06M	USD	3 Qtrs
Principal payments of notes payable	`RepaymentsOfNotesPayable`	$110.25K	USD	3 Qtrs
Principal payments of notes payable	`RepaymentsOfNotesPayable`	-	USD	3 Qtrs
Proceeds from issuance of common stock net	`ProceedsFromIssuanceOfCommonStock`	$23.42M	USD	3 Qtrs
Proceeds from issuance of common stock net	`ProceedsFromIssuanceOfCommonStock`	$19.82M	USD	3 Qtrs
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	$636.52K	USD	3 Qtrs
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	$569.43K	USD	3 Qtrs
Proceeds from warrants exercised for common stock	`ProceedsFromWarrantExercises`	$2.12M	USD	3 Qtrs
Proceeds from warrants exercised for common stock	`ProceedsFromWarrantExercises`	$7.19M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$27.53M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$26.10M	USD	3 Qtrs
Net increase /(decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$8.95M	USD	3 Qtrs
Net increase /(decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-28.73M	USD	3 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$7.54M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$36.28M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$11.45M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$7.54M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$36.28M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$11.45M	USD	Point-in-time
Cashless exercise of warrants for common stock	`CashlessEexerciseOfWarrants`	-	USD	3 Qtrs
Cashless exercise of warrants for common stock	`CashlessEexerciseOfWarrants`	$43.00	USD	3 Qtrs
Cashless exercise of options for common stock	`NoncashOrPartNoncashAcquisitionPayablesAssumed1`	-	USD	3 Qtrs
Cashless exercise of options for common stock	`NoncashOrPartNoncashAcquisitionPayablesAssumed1`	$90.00	USD	3 Qtrs
Income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Interest	`InterestPaidNet`	-	USD	3 Qtrs
Interest	`InterestPaidNet`	$2.42K	USD	3 Qtrs

Stockholders Equity 47 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$96.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$91.15M	USD	Point-in-time
Balance	`StockholdersEquity`	$113.16M	USD	Point-in-time
Balance	`StockholdersEquity`	$132.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$72.69M	USD	Point-in-time
Balance	`StockholdersEquity`	$122.21M	USD	Point-in-time
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$115.68M	USD	Point-in-time
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$8.01M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$5.85M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$8.27M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$5.24M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$7.30M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$5.04M	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$481.45K	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$1.57M	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$175.01K	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$1.46M	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$3.04M	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$2.58M	USD	1 Quarter
Cashless warrant exercise	`CashlessExerciseOfWarrantsValue`	-	USD	1 Quarter
Cashless warrant exercise	`CashlessExerciseOfWarrantsValue`	-	USD	1 Quarter
Options exercised for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$52.16K	USD	1 Quarter
Options exercised for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$73.02K	USD	1 Quarter
Options exercised for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$457.62K	USD	1 Quarter
Options exercised for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$105.88K	USD	1 Quarter
Equity offering, net	`StockIssuedDuringPeriodValueOther`	$19.86M	USD	1 Quarter
Equity offering costs	`EquityOfferingCosts`	$-38.42K	USD	1 Quarter
Equity offering costs	`EquityOfferingCosts`	$-42.01K	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$467.77K	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$49.50K	USD	1 Quarter
ATM offering, net of offering costs	`ATMOfferingNetOfOfferingCosts`	$23.46M	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-42.61M	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-10.67M	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-11.12M	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-26.55M	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-16.90M	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-22.22M	USD	1 Quarter
Balance	`StockholdersEquity`	$96.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$91.15M	USD	Point-in-time
Balance	`StockholdersEquity`	$113.16M	USD	Point-in-time
Balance	`StockholdersEquity`	$132.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$72.69M	USD	Point-in-time
Balance	`StockholdersEquity`	$122.21M	USD	Point-in-time
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$115.68M	USD	Point-in-time
Warrants issued for license agreement	`StockIssuedDuringPeriodValueNewIssues`	$10,241.60B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.